$SAVA Pathetic posts from shorts 6 days after SAVA hits a 52 week high. A little selling is to be expected by the MC still does not match the PH2b very impressive break thru study results in AD in which a panel of 11 biomarkers show slowing or improvement in patients with mild to moderate AD, plus some studies showing cognitive improvement too. Absolutely unheard of and could lead to a AD break linking AB42 to p-Tau181 pathology. Huge Potential for AD patients.
  • 6